Results 61 to 70 of about 515,964 (279)

Perbedaan Kadar Corticotropin Releasing Hormone Dan Aktivitas Katalase Pada Persalinan Preterm Dan Aterm [PDF]

open access: yes, 2020
Persalinan preterm adalah proses pengeluaran hasil konsepsi sebelum 37 minggu dan janin yang lahir beresiko mengalami komplikasi akibat imaturitas organ tubuh.
Miskah, Indah Syahid MP
core  

New insights into epileptic spasm generation and treatment from the TTX animal model

open access: yesEpilepsia Open, EarlyView.
Abstract Currently, we have an incomplete understanding of the mechanisms underlying infantile epileptic spasms syndrome (IESS). However, over the past decade, significant efforts have been made to develop IESS animal models to provide much‐needed mechanistic information for therapy development.
John W. Swann   +2 more
wiley   +1 more source

cAMP-dependent cell differentiation triggered by activated CRHR1 in hippocampal neuronal cells

open access: yesScientific Reports, 2017
Corticotropin-releasing hormone receptor 1 (CRHR1) activates the atypical soluble adenylyl cyclase (sAC) in addition to transmembrane adenylyl cyclases (tmACs).
Carolina Inda   +6 more
doaj   +1 more source

Prenatal betamethasone–postnatal N‐methyl‐D‐aspartic acid model of spasms: Update on mechanisms and treatments

open access: yesEpilepsia Open, EarlyView.
Abstract Infantile epilepsy spasms syndrome (IESS), formerly known as infantile spasms or West Syndrome, is a severe epilepsy syndrome affecting about 3 in 10,000 newborns in the United States. Characterized by clusters of epileptic spasms, interictal hypsarrhythmia, and developmental delays, IESS has diverse causes, including structural‐metabolic ...
Kayla Vieira   +5 more
wiley   +1 more source

Ketogenic diet for infantile epileptic spasms

open access: yesEpilepsia Open, EarlyView.
Abstract Approximately half of all cases of Infantile Epileptic Spasms Syndrome (IESS) do not respond to vigabatrin and hormonal therapies. There is no clear consensus as to the second‐line therapy for IESS. Ketogenic diet (KD) has emerged as an effective treatment for certain drug‐resistant epilepsies and in many cases of IESS.
Morris H. Scantlebury   +3 more
wiley   +1 more source

Pancreatic α‐cell dysfunction associated with equine insulin dysregulation

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background Insulin dysregulation (ID) in horses is characterised by insulin resistance and exaggerated insulin responses, yet the underlying endocrine mechanisms remain incompletely understood. In humans, α‐cell dysfunction characterised by exaggerated glucagon secretion contributes to metabolic disease; however, the role of pancreatic α‐cell ...
Sanna Lindåse   +3 more
wiley   +1 more source

tHE ROLE OF corticotropin-RELEASING HORMONE IN INITIATION OF LABOR

open access: yesМедицинский вестник Юга России, 2013
Purpose: To determine the content of corticotropin-releasing hormone, substance P, prostaglandin F2a, neurokinins A and B, interleukins 6 and 8, relaxin and cortisol in the blood serum and amniotic fluid and to evaluate the influence of these markers on ...
T. G. Arutyunyan   +2 more
doaj   +1 more source

Relevance of inferior petrosal sinus sampling in the diagnosis of Cushing’s syndrome: a case report

open access: yesAdvances in Laboratory Medicine, 2022
Non-specific signs and symptoms of Cushing’s syndrome (CS) can pose a diagnostic challenge.
García Clara Jiménez   +4 more
doaj   +1 more source

Corticotropin releasing hormone, interleukin-1 alpha, and tumor necrosis factor-alpha share characteristics of stress mediators

open access: yes, 1991
Interleukin-1α and tumor necrosis factor-α induce an increase in pain thresholds in the rat. We now show that also the corticotropin releasing hormone induces an analgesic effect that, similarly to what is observed with the two cytokines, is not ...
A.E. PANERAI   +4 more
core   +1 more source

Growth Hormone (GH)-Releasing Peptide Stimulation of GH Release from Human Somatotroph Adenoma Cells: Interaction with GH-Releasing Hormone, Thyrotropin- Releasing Hormone, and Octreotide. [PDF]

open access: yes, 1994
The synthetic hexapeptide GH-releasing peptide (GHRP; His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) specifically stimulates GH secretion in humans in vivo and in animals in vitro and in vivo via a still unknown receptor and mechanism.
Strasburger, Christian J.   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy